David E. Tupper - Concepedia

Author

David E. Tupper

Also Known As

D E Tupper, D Tupper, D. E. TUPPER, D. E. Tupper, D.E. Tupper, DAVID E. TUPPER, David E Tupper, David E. Tupper, David Tupper, Tupper, David

131

Publications

Citations

H-Index

118

Concepts

All Affiliations

Hennepin County Medical Center Eli Lilly (United States)University of Minnesota HealthPartners University of Minnesota Medical Center

About

David E. Tupper is an author at Hennepin County Medical Center specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.4K
2	Engineering	7	7	116
3	Natural Sciences	7	7	232
4	Health Sciences	3	3	126
5	Education	1	1	13

David E. Tupper

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Cognitive impairment in hemodialysis patients is common Anne M. Murray, David E. Tupper, David S. Knopman, Neurology	2006	691
Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: a randomised trial Tom P. Aufderheide, Ralph J. Frascone, Marvin A. Wayne, The Lancet Trauma ResuscitationCardiac AnaesthesiaCardiopulmonary ResuscitationRandomised TrialPatient Safety	2011	261
Disposition and biotransformation of the antipsychotic agent olanzapine in humans. Kelem Kassahun, Edward L. Mattiuz, Eldon H. Nyhart, PubMed Plasma CompartmentPsychotropic MedicationPsychopharmacologyPharmacotherapySocial Sciences	1997	212
Cognitive Impairment in Peritoneal Dialysis Patients Paramjit Kalirao, Sarah Pederson, Robert N. Foley, American Journal of Kidney Diseases NeuropsychologyAlzheimer's DiseaseMedicineCognitive DysfunctionDementia	2011	172
Acute Variation in Cognitive Function in Hemodialysis Patients: A Cohort Study With Repeated Measures Anne M. Murray, Sarah Pederson, David E. Tupper, American Journal of Kidney Diseases Neuropsychological FunctioningHemodialysis PatientsBrain FunctionMedicineCognitive Dysfunction	2007	122
Heteroarenobenzodiazepines. 3. 4-Piperazinyl-10H-thieno[2,3-b][1,5]benzodiazepines as potential neuroleptics Jiban K. Chakrabarti, Linda Horsman, Terrence M. Hotten, Journal of Medicinal Chemistry Favorable SeparationMedicinal ChemistryPsychoactive DrugPsychiatryMedicine	1980	78
Treatment of non-traumatic out-of-hospital cardiac arrest with active compression decompression cardiopulmonary resuscitation plus an impedance threshold device Ralph J. Frascone, Marvin A. Wayne, Robert A. Swor, Resuscitation Trauma ResuscitationImpedance Threshold DeviceCardiopulmonary ResuscitationPatient SafetyTraumatic Cardiac Arrest	2013	67
The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function Anne M. Murray, Elizabeth J. Bell, David E. Tupper, American Journal of Kidney Diseases Alzheimer's DiseaseCognitive PerformanceBrain FunctionMedicineBrain Health	2015	64
Synthesis and Pharmacological Characterization of C4-Disubstituted Analogs of 1<i>S</i>,2<i>S</i>,5<i>R</i>,6<i>S</i>-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: Identification of a Potent, Selective Metabotropic Glutamate Receptor Agonist and Determination of Agonist-Bound Human mGlu2 and mGlu3 Amino Terminal Domain Structures James A. Monn, Lourdes Prieto, Lorena Taboada, Journal of Medicinal Chemistry Pharmacological CharacterizationPharmacotherapyExperimental PharmacologyCompound 2C4-disubstituted Analogs	2015	59
Synthesis and Pharmacological Characterization of <i>C</i>4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1<i>R</i>,2<i>S</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-2-Amino-4-(1<i>H</i>-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective mGlu<sub>2</sub> Receptor Agonist James A. Monn, Lourdes Prieto, Lorena Taboada, Journal of Medicinal Chemistry Pharmacological CharacterizationImmunologyPharmacotherapyPharmaceutical ChemistryMolecular Pharmacology	2015	56

Page 1